Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
KROS
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w low +1.9%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
keros
therapeutics
nasdaq
high
last
trading
rating
compared
2023
period
clinical
patients
previous
nyse
announced
price
today
closed
mass
stage
KROS
Keros Therapeutics, Inc. Common Stock
Stonvex
StonvexStonvexStonvexStonvex